Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B2 | P37059 | 4/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | UQCRB | P14927 | 1/20 | 0.68 |
| ▸ | IL1RN | P18510 | 1/20 | 0.66 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.66 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.66 |
| ▸ | HTR6 | P50406 | 3/20 | 0.65 |
| ▸ | PKM | P14618 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | GFER | P55789 | 1/20 | 0.61 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.61 |
| ▸ | CYTH2 | Q99418 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | PGR | P06401 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16720181 | 0.91 | HSD17B2 (0.71) | HSD17B2KMT2AUQCRBIL1RNKEAP1 | |
| SCHEMBL6297524 | 0.90 | HSD17B2 (0.70) | HSD17B2KMT2AUQCRBIL1RNKEAP1 | |
| SCHEMBL16719342 | 0.89 | IL1RN (0.66) | HSD17B2KMT2AUQCRBIL1RNKEAP1 | |
| SCHEMBL1592342 | 0.89 | HSD17B2 (0.79) | HSD17B2KMT2AUQCRBHTR6PKM | |
| SCHEMBL9001184 | 0.87 | KEAP1 (0.79) | KMT2AIL1RNKEAP1ERAP1HTR6 | |
| SCHEMBL6302122 | 0.86 | HSD17B2 (0.65) | HSD17B2KMT2AUQCRBHTR6PKM | |
| SCHEMBL7180209 | 0.85 | CYTH2 (0.67) | HSD17B2KMT2AUQCRBIL1RNKEAP1 | |
| SCHEMBL3259544 | 0.85 | HSD17B2 (0.72) | HSD17B2KMT2AUQCRBPKMMEN1 | |
| SCHEMBL8864887 | 0.85 | HTR6 (0.73) | HSD17B2KMT2AUQCRBKEAP1HTR6 | |
| SCHEMBL6302356 | 0.85 | CYP19A1 (0.78) | HSD17B2KMT2AUQCRBPKMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105939867-B | Thermal recording medium | 三菱制纸株式会社 | 2018-05-11 | — | — | CN | disclosed |
| US-9834022-B2 | Thermal recording material | MITSUBISHI PAPER MILLS LIMITED (JP) | 2017-12-05 | — | — | US | disclosed |
| EP-3031611-B1 | THERMAL RECORDING MATERIAL | MITSUBISHI PAPER MILLS LTD (JP) | 2017-09-27 | — | — | EP | disclosed |
| US-20160332469-A1 | THERMAL RECORDING MATERIAL | MITSUBISHI PAPER MILLS LIMITED (JP) | 2016-11-17 | — | — | US | disclosed |
| CN-105939867-A | Heat-sensitive recording material | 三菱制纸株式会社 | 2016-09-14 | — | — | CN | disclosed |
| EP-3031611-A1 | THERMAL RECORDING MATERIAL | Mitsubishi Paper Mills Limited (JP) | 2016-06-15 | — | — | EP | disclosed |
| EP-2096149-B1 | INK FOR SCRATCH COLORING AND SHEET WITH INVISIBLE INFORMATION PRINTED | MITSUBISHI PAPER MILLS LTD (JP) | 2014-10-22 | — | — | EP | disclosed |
| US-8288313-B2 | Thermal recording material | MITSUBISHI PAPER MILLS LIMITED (JP) | 2012-10-16 | — | — | US | disclosed |
| US-8283285-B2 | Scratch color-developable ink and invisible information printed sheet | MITSUBISHI PAPER MILLS LIMITED (JP) | 2012-10-09 | — | — | US | disclosed |
| US-20100069240-A1 | THERMAL RECORDING MATERIAL | MITSUBISHI PAPER MILLS LIMITED (JP) | 2010-03-18 | — | — | US | disclosed |
| WO-2005034960-A1 | TREATMENT OF DISEASES ASSOCIATED WITH THE EGR-1 ENHANCER ELEMENT | RESVERLOGIX CORP. (CA) | 2005-04-21 | — | — | WO | disclosed |
| US-20050080024-A1 | Nitric oxide donating derivatives for the treatment of cardiovascular disorders | RESVERLOGIX CORP. (CA) | 2005-04-14 | — | — | US | disclosed |
| US-20050080021-A1 | Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders | RESVERLOGIX CORP. (CA) | 2005-04-14 | — | — | US | disclosed |
| WO-2005032559-A1 | NITRIC OXIDE DONATING DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS | RESVERLOGIX CORP. (CA) | 2005-04-14 | — | — | WO | disclosed |
| US-6579829-B2 | Aromatic sulfonamide compound | MITSUI CHEMICALS, INC. (JP) | 2003-06-17 | — | — | US | disclosed |
| WO-2002078970-A1 | HEAT SENSITIVE RECORDING MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-10-10 | — | — | WO | disclosed |
| EP-1138517-A2 | Developer composition and heat sensitive recording material | Mitsui Chemicals, Inc. (JP) | 2001-10-04 | — | — | EP | disclosed |
| EP-0125522-B1 | COLOR PHOTOGRAPHIC MATERIALS | FUJI PHOTO FILM CO., LTD. (JP) | 1989-01-11 | — | — | EP | disclosed |
| US-4530899-A | Silver halide photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1985-07-23 | — | — | US | disclosed |
| EP-0125522-A2 | Color photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1984-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080024-A1 | Nitric oxide donating derivatives for the treatment of cardiovascular disorders | NOS2, NOS3, NOS1 | HSD17B2 178/4885KMT2A 2695/4885UQCRB 1114/4885 |
| US-20050080021-A1 | Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders | NOS2, NOS1, NOS3 | HSD17B2 167/4885KMT2A 2279/4885UQCRB 1252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.